Abstract 3280: Type I IFN receptor signaling in myeloid and T cells drives antitumor immunity elicited by intratumoral delivery of immunogenic recombinant modified vaccinia virus AnkaraYueqi Wang, Liang Deng, Ning Yang et al.|Cancer Research|2025Cited by 0